phosphatidylcholines has been researched along with nocodazole in 3 studies
| Studies (phosphatidylcholines) | Trials (phosphatidylcholines) | Recent Studies (post-2010) (phosphatidylcholines) | Studies (nocodazole) | Trials (nocodazole) | Recent Studies (post-2010) (nocodazole) |
|---|---|---|---|---|---|
| 32,204 | 443 | 5,593 | 3,078 | 0 | 655 |
| Protein | Taxonomy | phosphatidylcholines (IC50) | nocodazole (IC50) |
|---|---|---|---|
| Chain A, Glutathione-requiring prostaglandin D synthase | Homo sapiens (human) | 65 | |
| nuclear receptor subfamily 0 group B member 1 | Homo sapiens (human) | 0.8334 | |
| Tyrosine-protein kinase ABL1 | Homo sapiens (human) | 0.64 | |
| Tubulin alpha-1A chain | Sus scrofa (pig) | 1.3775 | |
| Tubulin beta chain | Sus scrofa (pig) | 0.76 | |
| Tubulin beta-4A chain | Homo sapiens (human) | 1.2975 | |
| Tubulin beta chain | Homo sapiens (human) | 1.2975 | |
| Tubulin alpha-3C chain | Homo sapiens (human) | 1.2975 | |
| Adenosine receptor A2a | Homo sapiens (human) | 7.509 | |
| Tubulin alpha-1B chain | Homo sapiens (human) | 1.2975 | |
| Tubulin alpha-4A chain | Homo sapiens (human) | 1.2975 | |
| Tubulin beta-4B chain | Homo sapiens (human) | 1.2975 | |
| Sodium-dependent dopamine transporter | Homo sapiens (human) | 6.232 | |
| Tubulin beta-3 chain | Homo sapiens (human) | 1.2975 | |
| Tubulin beta-2A chain | Homo sapiens (human) | 1.2975 | |
| Tubulin beta-8 chain | Homo sapiens (human) | 1.2975 | |
| Tubulin beta-2B chain | Bos taurus (cattle) | 2.3 | |
| Tubulin alpha-3E chain | Homo sapiens (human) | 1.2975 | |
| Tubulin alpha-1A chain | Homo sapiens (human) | 1.2975 | |
| Similar to alpha-tubulin isoform 1 | Bos taurus (cattle) | 2.3 | |
| Similar to alpha-tubulin isoform 1 | Bos taurus (cattle) | 2.3 | |
| Tubulin alpha-1C chain | Homo sapiens (human) | 1.2975 | |
| Tubulin beta-6 chain | Homo sapiens (human) | 1.2975 | |
| Tubulin beta-2B chain | Homo sapiens (human) | 1.2975 | |
| Tubulin beta-1 chain | Homo sapiens (human) | 1.2975 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Adamo, S; Coletti, D; Molinaro, M; Naro, F; Palleschi, S; Silvestroni, L | 1 |
| Grafton, J; Hutson, E; Kidd, D; Kobayashi, M; McNulty, S; Rumsby, M | 1 |
| Berman, E; Cohen, JS; Mardor, Y; Ringel, I; Sterin, M | 1 |
3 other study(ies) available for phosphatidylcholines and nocodazole
| Article | Year |
|---|---|
Vesicle-mediated phosphatidylcholine reapposition to the plasma membrane following hormone-induced phospholipase D activation.
Topics: Acrylamide; Androstadienes; Animals; Arginine Vasopressin; Brefeldin A; Cell Line; Cell Membrane; Cytochalasin B; Diphenylhexatriene; Enzyme Activation; Exocytosis; Fluorescent Dyes; Kinetics; Membrane Lipids; Muscle, Skeletal; Nocodazole; Paclitaxel; Phosphatidylcholines; Phospholipase D; Rats; Wortmannin; Zinc | 2000 |
Protein kinase C activation by 12-0-tetradecanoylphorbol 13-acetate in CG-4 line oligodendrocytes stimulates turnover of choline and ethanolamine phospholipids by phospholipase D and induces rapid process contraction.
Topics: Animals; Cell Line; Cell Surface Extensions; Enzyme Activation; Enzyme Activators; Enzyme Inhibitors; Nocodazole; Oligodendroglia; Phosphatidylcholines; Phosphatidylethanolamines; Phospholipase D; Phospholipids; Protein Kinase C; Rats; Tetradecanoylphorbol Acetate | 2001 |
Levels of phospholipid metabolites in breast cancer cells treated with antimitotic drugs: a 31P-magnetic resonance spectroscopy study.
Topics: Antineoplastic Agents; Breast Neoplasms; Cell Cycle; Cell Division; Cell Membrane; Collagen; Doxorubicin; Drug Combinations; G2 Phase; Laminin; Methotrexate; Mitosis; Nocodazole; Nuclear Magnetic Resonance, Biomolecular; Paclitaxel; Phosphatidylcholines; Phospholipids; Phosphorus; Proteoglycans; Tumor Cells, Cultured; Vincristine | 2001 |